On Thursday shares of Lowe’s Companies Inc. (NYSE:LOW) closed at $72.86. Company’s sales growth for last 5 years was 3.60% and EPS growth for next 5 years is recorded as 18.20%. Lowe’s Companies Inc. (NYSE:LOW) has announced a new $5 billion worth stock buyback program. The new authorization will add to the balance of the existing repurchase authorization, which was $2.4 billion as of Jan 30, 2015. Also, the company declared a quarterly cash dividend of 23 cents per share payable on May 6, 2015, to shareholders of record as of Apr 22. The dividend yield based on the last closing stock price is 1.2%.
Sage Therapeutics, Inc. (NASDAQ:SAGE) in last trading activity advanced 1.36% to close at $45.61. Company weekly performance is -11.54% while its quarterly performance stands at 17.31%. Sage Therapeutics, Inc. (NASDAQ:SAGE) is -17.09% away from its 52 week high. Vetr upgraded shares of SAGE Therapeutics (NASDAQ:SAGE) from a strong sell rating to a sell rating in a research note released on Monday morning. They currently have $50.68 target price on the stock.
On last trading day Bebe Stores, Inc. (NASDAQ:BEBE) decreased -3.98% to close at $3.62. Its volatility for the week is 6.24% while volatility for the month is 5.40%. BEBE’s sales growth for past 5 years was -5.10% and its EPS growth for past 5 years was -41.00%. Bebe Stores, Inc. (NASDAQ:BEBE) monthly performance is 0.56%. On March 18, it was reported that, A California federal judge shot down Bebe Stores Inc. (NASDAQ:BEBE)’s bid to put a Telephone Consumer Protection Act proposed class action against it on hold while the Federal Communications Commission mulls a petition on the definition of an autodialer, saying that the petition has dubious relevancy. U.S. District Judge Yvonne Gonzalez-Rogers ruled that expeditiously resolving the case outweighed issuing a stay since it’s not known when the FCC will rule on the petition.
Exact Sciences Corporation (NASDAQ:EXAS) has 0.90% insider ownership while its institutional ownership stands at 95.40%. In last trading activity company’s stock closed at $21.33. On March 19, Exact Sciences Corp. (NASDAQ: EXAS) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced an agreement to co-promote Exact Sciences’ Cologuard®, the first and only FDA-approved noninvasive stool DNA screening test for colorectal cancer. The agreement provides for the near-term expansion of Cologuard promotional efforts through the use of Ironwood’s clinical sales specialists to more than double the number of physicians reached in the United States.
On Thursday shares of Regions Financial Corporation (NYSE:RF) closed at $9.31. Company’s sales growth for last 5 years was -7.40% and EPS growth for next 5 years is recorded as 8.60%. Regions Financial Corporation (NYSE:RF) is scheduled to release its first quarter 2015 financial results on Tuesday, April 21, 2015. Executives from the company will review Regions’ first quarter results via teleconference and live audio webcast beginning at 11 a.m. ET.